Literature DB >> 10684938

Requirement for PCNA and RPA in interstrand crosslink-induced DNA synthesis.

L Li1, C A Peterson, X Zhang, R J Legerski.   

Abstract

Proliferating nuclear cell antigen (PCNA) and replication protein A (RPA) have proven to be essential elements in many aspects of DNA metabolism including replication, repair and recombination. We have developed an in vitro assay in which the presence of an interstrand crosslink stimulates the incorporation of radiolabeled nucleotides into both damaged and undamaged plasmid DNAs. Using this assay we have investigated the roles of PCNA and RPA in crosslink-induced DNA synthesis. p21, a potent inhibitor of PCNA, was found to strongly inhibit crosslink-induced incorporation. Addition of exogenous PCNA partially restored the resynthesis activity. Likewise, neutralization of RPA by monoclonal antibodies also inhibited incorporation, but the effect was somewhat more pronounced on the undamaged plasmid than the damaged plasmid. Addition of excess RPA also partially reversed antibody inhibition. These results indicate that both PCNA and RPA are required for efficient in vitro DNA resynthesis induced by interstrand crosslinks.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10684938      PMCID: PMC111036          DOI: 10.1093/nar/28.6.1424

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  36 in total

1.  XRCC3 promotes homology-directed repair of DNA damage in mammalian cells.

Authors:  A J Pierce; R D Johnson; L H Thompson; M Jasin
Journal:  Genes Dev       Date:  1999-10-15       Impact factor: 11.361

Review 2.  The in vitro replication of DNA containing the SV40 origin.

Authors:  J Hurwitz; F B Dean; A D Kwong; S H Lee
Journal:  J Biol Chem       Date:  1990-10-25       Impact factor: 5.157

Review 3.  Animal virus DNA replication.

Authors:  M D Challberg; T J Kelly
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

Review 4.  Initiation of eukaryotic DNA replication in vitro.

Authors:  B Stillman
Journal:  Annu Rev Cell Biol       Date:  1989

5.  mus308 mutants of Drosophila exhibit hypersensitivity to DNA cross-linking agents and are defective in a deoxyribonuclease.

Authors:  J B Boyd; K Sakaguchi; P V Harris
Journal:  Genetics       Date:  1990-08       Impact factor: 4.562

6.  Replication of simian virus 40 origin-containing DNA in vitro with purified proteins.

Authors:  C R Wobbe; L Weissbach; J A Borowiec; F B Dean; Y Murakami; P Bullock; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

7.  Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein.

Authors:  G Prelich; C K Tan; M Kostura; M B Mathews; A G So; K M Downey; B Stillman
Journal:  Nature       Date:  1987 Apr 2-8       Impact factor: 49.962

8.  Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta.

Authors:  R Bravo; R Frank; P A Blundell; H Macdonald-Bravo
Journal:  Nature       Date:  1987 Apr 2-8       Impact factor: 49.962

9.  Inhibition of nucleotide excision repair by the cyclin-dependent kinase inhibitor p21.

Authors:  Z Q Pan; J T Reardon; L Li; H Flores-Rozas; R Legerski; A Sancar; J Hurwitz
Journal:  J Biol Chem       Date:  1995-09-15       Impact factor: 5.157

10.  Cellular factors required for multiple stages of SV40 DNA replication in vitro.

Authors:  M P Fairman; B Stillman
Journal:  EMBO J       Date:  1988-04       Impact factor: 11.598

View more
  12 in total

1.  hMutSbeta is required for the recognition and uncoupling of psoralen interstrand cross-links in vitro.

Authors:  Nianxiang Zhang; Xiaoyan Lu; Xiaoshan Zhang; Carolyn A Peterson; Randy J Legerski
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

2.  Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells.

Authors:  I U De Silva; P J McHugh; P H Clingen; J A Hartley
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

Review 3.  Formation and repair of interstrand cross-links in DNA.

Authors:  David M Noll; Tracey McGregor Mason; Paul S Miller
Journal:  Chem Rev       Date:  2006-02       Impact factor: 60.622

4.  Chromatin-bound PCNA complex formation triggered by DNA damage occurs independent of the ATM gene product in human cells.

Authors:  A S Balajee; C R Geard
Journal:  Nucleic Acids Res       Date:  2001-03-15       Impact factor: 16.971

Review 5.  Repair of DNA interstrand cross-links during S phase of the mammalian cell cycle.

Authors:  Randy J Legerski
Journal:  Environ Mol Mutagen       Date:  2010-07       Impact factor: 3.216

Review 6.  Initiation of DNA interstrand cross-link repair in mammalian cells.

Authors:  Erica M Hlavin; Michael B Smeaton; Paul S Miller
Journal:  Environ Mol Mutagen       Date:  2010-07       Impact factor: 3.216

7.  Defining the function of xeroderma pigmentosum group F protein in psoralen interstrand cross-link-mediated DNA repair and mutagenesis.

Authors:  Zhiwen Chen; Xiaoxin Susan Xu; Jason Harrison; Gan Wang
Journal:  Biochem J       Date:  2004-04-01       Impact factor: 3.857

8.  hSnm1 colocalizes and physically associates with 53BP1 before and after DNA damage.

Authors:  Christopher T Richie; Carolyn Peterson; Tao Lu; Walter N Hittelman; Phillip B Carpenter; Randy J Legerski
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

9.  Effect of cross-link structure on DNA interstrand cross-link repair synthesis.

Authors:  Michael B Smeaton; Erica M Hlavin; Anne M Noronha; Sebastian P Murphy; Christopher J Wilds; Paul S Miller
Journal:  Chem Res Toxicol       Date:  2009-07       Impact factor: 3.739

10.  XPF-ERCC1 participates in the Fanconi anemia pathway of cross-link repair.

Authors:  Nikhil Bhagwat; Anna L Olsen; Anderson T Wang; Katsuhiro Hanada; Patricia Stuckert; Roland Kanaar; Alan D'Andrea; Laura J Niedernhofer; Peter J McHugh
Journal:  Mol Cell Biol       Date:  2009-10-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.